To define changes in RD3 transcription in MYCN-na NB with IMCT, we compared RD3 mRNA levels (ISH, Fig. 1a) in a panel of cell lines derived from stage 4 patients during diagnosis or after IMCT. This evidence concerns the gene RD3 and neuroblastoma.